Search - Centre de recherche en cancérologie Nantes-Angers Unité Mixte de Recherche 892 Inserm - 6299 CNRS Access content directly

Filter your results

3 Results
hal_authIdPerson_i : 758218

Influence of tumour burden on trastuzumab pharmacokinetics in HER2 positive non-metastatic breast cancer

Guillemette Bernadou , Mario Campone , Jean-Louis Merlin , Valérie Gouilleux-Gruart , Thomas Bachelot et al.
British Journal of Clinical Pharmacology, 2016, 81 (5), pp.941-948. ⟨10.1111/bcp.12875⟩
Journal articles hal-01252102v1

Trastuzumab as a preoperative monotherapy does not inhibit HER2 downstream signaling in HER2-positive breast cancer

Maëva Lion , Alexandre Harlé , Julia Salleron , Carole Ramacci , Mario Campone et al.
Oncology Letters, 2016, 12 (3), pp.2028-2032. ⟨10.3892/ol.2016.4891⟩
Journal articles hal-01418865v1

Trastuzumab (T) and everolimus (E) pharmacokinetics (PK) in HER2 positive (+) primary breast cancer (BC) patients (pts): Unicancer RADHER trial results

Guillemette Bernadou , Keyvan Rezai , Jean-Louis Merlin , Mario Campone , François Lokiec et al.
2013 ASCO Annual Meeting, May 2013, Chicago, Il, United States. pp.CDROM
Conference papers hal-00831929v1